In a challenging market environment, Immunic, Inc. (NASDAQ:IMUX) stock has recorded a new 52-week low, dipping to $0.92. The biopharmaceutical company, which focuses on developing treatments for ...
AM(IST)on Tuesday in a weak market. Abbott India Ltd.(up 0.47 per cent) and Glenmark Pharmaceuticals Ltd.(up 0.44 per cent) ...
Motilal Oswal Mutual Fund A/C Motilal Oswal Large and Midcap Fund acquired 10.55 lakh shares (0.92 percent) at the same price. The following trades took place via bulk deals on January 31. CPT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results